Literature DB >> 12695172

Effects of interferon alpha treatment on the clinical course of refractory Behçet's disease: an open study.

M Calgüneri, M A Oztürk, I Ertenli, S Kiraz, S Apraş, Z Ozbalkan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12695172      PMCID： PMC1754535          DOI： 10.1136/ard.62.5.492

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  13 in total

Review 1.  Management of sight-threatening uveitis: new therapeutic options.

Authors:  Matthias D Becker; Justine R Smith; Regina Max; Christoph Fiehn
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  Update on the therapy of Behçet disease.

Authors:  Zeinab Saleh; Thurayya Arayssi
Journal:  Ther Adv Chronic Dis       Date:  2014-05       Impact factor: 5.091

3.  Long-term efficacy and safety of interferon α-2a therapy in severe refractory ophthalmic Behcet's disease.

Authors:  Hadise Kavandi; Alireza Khabbazi; Sousan Kolahi; Mehrzad Hajialilo; Farid Karkon Shayan; Mohammad Oliaei
Journal:  Clin Rheumatol       Date:  2016-05-27       Impact factor: 2.980

Review 4.  Neuro-Behçet's syndrome: differential diagnosis and management.

Authors:  Erdal Diri; Louis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2006-08       Impact factor: 4.592

Review 5.  Outcome measures used in clinical trials for Behçet syndrome: a systematic review.

Authors:  Gulen Hatemi; Peter A Merkel; Vedat Hamuryudan; Maarten Boers; Haner Direskeneli; Sibel Z Aydin; Hasan Yazici
Journal:  J Rheumatol       Date:  2014-02-01       Impact factor: 4.666

6.  Results of interferon-alfa therapy in patients with Behçet uveitis.

Authors:  Ilknur Tugal-Tutkun; Esra Güney-Tefekli; Meri Urgancioglu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-12       Impact factor: 3.117

7.  Transverse myelitis in a patient with Behcet's disease: favorable outcome with a combination of interferon-alpha.

Authors:  Meral Calgüneri; Ahmet Mesut Onat; M Akif Oztürk; Levent Ozçakar; Kemal Ureten; Ali Akdogan; Ihsan Ertenli; Sedat Kiraz
Journal:  Clin Rheumatol       Date:  2004-10-26       Impact factor: 2.980

Review 8.  Behçet Disease: An Update for Dermatologists.

Authors:  Erkan Alpsoy; Burcin Cansu Bozca; Asli Bilgic
Journal:  Am J Clin Dermatol       Date:  2021-06-01       Impact factor: 7.403

Review 9.  Update on the treatment of Behçet's syndrome.

Authors:  Sinem Nihal Esatoglu; Gulen Hatemi
Journal:  Intern Emerg Med       Date:  2019-01-25       Impact factor: 3.397

10.  Interferons and their potential in the treatment of ocular inflammation.

Authors:  Friederike Mackensen; Regina Max; Matthias D Becker
Journal:  Clin Ophthalmol       Date:  2009-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.